Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial

The aim of the study was to compare efficacy and safety of first-line palliative chemotherapy with (EOX) epirubicin/oxaliplatin/capecitabine and (mDCF) docetaxel/cisplatin/5FU/leucovorin regimens for untreated advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma. Fifty-six pati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Med Oncol
Main Authors: Ochenduszko, Sebastian, Puskulluoglu, Miroslawa, Konopka, Kamil, Fijorek, Kamil, Urbanczyk, Katarzyna, Budzynski, Andrzej, Matlok, Maciej, Lazar, Agata, Sinczak-Kuta, Anna, Pedziwiatr, Michal, Krzemieniecki, Krzysztof
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2015
Assuntos:
Original Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4564435/
https://ncbi.nlm.nih.gov/pubmed/26354521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-015-0687-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares